HPGDS and allergic asthma: In our preceding study, we saw that PGD2 was elevated in the bronchoalveolar fluid of mice that received intranasal LPS [12], which was a novel observation, compared to the very well explored elevated PGD2 levels in BAL fluid of patients suffering from allergic asthma [28] and allergic lung inflammation in mice [34,35].